Skip to content

VITRO BIOPHARMA, INC.

CIK 0000793171

← back to feed
Revenue (TTM)
$2.1M
+10.8% YoY Q2 Jun 2026
Net Income (TTM)
−$5.84M
−9.9% YoY Q2 Jun 2026
EPS Diluted (TTM)
−$1.32
−10.4% YoY Q2 Jun 2026
Gross Margin
79.7%
Q2 Jun 2026
Operating Margin
-206.9%
Q2 Jun 2026
Net Margin
-278.5%
Q2 Jun 2026
Free Cash Flow (TTM)
−$3.69M
Q2 Jun 2026
Cash
$181.39K
Q2 Jun 2026
Total Debt
$10.01M
Q2 Jun 2026
Shares Outstanding
4.52M sh
Q2 Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings